Indication

Osteoarticular infection

1 clinical trial

1 product

Clinical trial

Efficacy of Dalbavancin in Osteoarticular Infections Associated With Hip and Knee Replacements

Status: Recruiting, Estimated PCD: 2024-09-30

Product